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1973-1091 Late Development of Left Ventricular
Hypertrophy After Anterior Infarction
Ken Hirose, Judd E. Reed, Thomas Behrenbeck, John A. Rumberger. Mayo Clinic
and Foundation, Rochester. MN
A number of investigations have shown progressive left ventricular dilatation
in sub-groups of patients after anterior wall myocardial infarction. However,
the magnitude and time course to which "reactive" left ventricular hypertro-
phy develops in such patients has been moot. A number of clinical studies
have examined long term consequences of post-infarction remodeling using
imaging methods which assess chamber enlargement but have, at best, lim-
ited precision to quantify serial changes in absolute left ventricular muscle
mass. We have followed 16 patients after an uncomplicated index anterior
wall myocardial infarction with serial electron beam CTstudies from hospital
discharge (d/c) to 4-5 years post-infarction. All patients were FC I-II. Abso-
lute global left ventricular end-diastolic volumes (LVEDV, ml), left ventricular
muscle masses (LVM, gm) and volumelmass ratios (VIM, an index of global
wall tension) were determined in 5 serial examinations performed at specific
dates after infarction, as shown below (data are mean ± SD and statistics
are for p < 0.05)
tricular remodeling and improves survival. However, it is unclear whether ex-
ercise tolerance is enhanced by ACEI treatment commenced early after MI
and continued long-term in an asymptomatic group of patients with acute MI.
We studied 64 consecutive patients with first, Q-wave, and uncomplicated
anterior MI. All received thrombolytic treatment with streptokinase and stan-
dard therapy. Patients were randomized to placebo (P. n = 22) or enalapril (E,
n = 44) treatment for 1 yr. Symptom-limited treadmill exercise was done at
months 1, 6 and 12 using a modified Naughton protocol. Both treatment
groups were comparable, with a baseline EF of 38.2 ± 3 in the P group and
37.4 ± 2 in the E group. Average time to study randomization was 30 hrs.
and 29 hrs. in the P and E groups after MI, respectively. Results: mean ± SD.
DP = Double Product
1m 6m 12m pIE vs. P)
Duration (sec)
P 707.7±23 814.8 ± 28 852.0 ± 26 P< 0.001
E 735.3 ± 22 986.9 ± 26 1192.9 ± 25 at 6& 12 months
Peak DP
P 2545 ± 12 275.3 ± 14 258.7 ± 19
E 237.1 ± 19 245.2 ± 18 260.7 ± 14 P ~ NS
die 6-weeks 6-months 1-year 4--5 years
LVEDV 136 ± 22 147 ± 25' 155 ± 26' 169 ± 30,#$ 168 ± 32,#$
LVM 136 ± 28 115 ± 22' 126 ± 33# 140 ± 33#$ 149 ± 30,#$
VIM 10 ± 03 1.3 ± 0.3' 1.3±0.3' 1.3 ± 0.4' 1.1 ± 0.2,#$&
Peak V02 was also significantly better in the Egroup at 6 m and 12 m. Thus,
despite similar peak DP and exercise duration at 1 m, the enalapril group
manifested better exercise competence at 6 m and 12 m. We conclude that
enalapril therapy in asymptomatic patients after anterior MI is associated
with greater long-term exercise capacity.
'vs. die, #vs. 6-weeks, $vs. 6-months. & vs l-year
Francine K. Welty, Murray A. Mittleman, Robert W. Healy, Stanley M. Lewis, James
E. MUller, Samuel J. Shubrooks, Jr. Institute for Prevention of Cardiovascular Disease
and Cardiovascular Division, Deaconess Hospital, Harvard Medical School, Boston, MA
Prognostic Value of TroponinT, Myoglobin and
CK-MB Mass in Patients with Chest Pain without
Acute Myocardial Infarction
Robbert J. de Winter, Jan H. Schotveld, Rudolph W. Koster, Auguste Sturk, Gerard
T. Sanders. Academic Medical Center. Amsterdam, The Netherlands
We investigated the prognostic value of Minimal Myocardial Damage (MMD)
as indicated by minor elevations of TroponinT (TnT), Myoglobin (Myo) and
CK-MB Mass (CK-MB) in 128 patients (pts) presented with chest pain at the
emergency room (ER) in whom an acute myocardial infarction (AMI) was ex-
cluded. Blood was drawn 3, 4, 5, 6, 7, 8, 12, 16, 20, 24 hours after the onset
of symptoms. Gold standard for AMI was a typical rise and fall of the CK-MB
curve with a peak> 14 nglml. A minor elevation of CK-MB was considered
present if the marker showed a typical rise and fall but with a peak below 14
nglml. TnT was considered abnormal if it showed a gradual rise with a high-
est value >0.01 nglml, Myo was considered abnormal if tie curve showed a
typical rise and fall with highest value at least tvvice the lowest value. Only
CK-MB results were reported to the attending physician. A documented his-
tory of Coronary Artery Disease (CAD) was defined as either previous AMI,
PTCA, CABG or a previous positive exercise test. Pts with unstable angina
were admitted to the CCU and stabilized with intravenous nitrates, aspirin,
heparin, tJ-blockers and Calcium-antagonists. PTCA or CABG was performed
for recurrent refractory angina. Follow up was completed after six months.
Major events were cardiac death and AMI, minor events were PTCA and
CABG.
Results: Diagnosis was unstable angina in 54 pts, stable angina in 59 pts,
atypical chest pain in 13 pts and arrhythmia in 2 pts. 75 Pts had a documented
history of CAD. MMD was indicated by abnormal TnT in 24 pts, by CK-MB in
13 pts and by Myo in 20 pts. There were 24 events (3 major and 21 minor).
20 events occurred in pts with a history of CAD (Relative Risk: RR, 95%
Confidence Limits CL: 3.53, 1.28-9.74). Events rate for TnT was 8/24 (RR:
2.17, 95% CL: 1.05-4.47), CK-MB 4/13 (RR: 1.77, 95% CL: 0.71--4.38) and
Myo 5/20 (RR: 1.42, 95%CL: 0.60-3.361
Conclusion: Minor elevations of CK-MB or Myoglobin have limited prog-
nostic value in pts presented at the ER with chest pain in whom an AMI has
been excluded. Minor elevation of TnT has some prognostic value but the
best predictor of future events in this group is a history of CAD.
Giovanna liuzza, Luigi M. Biasucci, Antonino Buffon, Gaetano Quaranta,
Giuseppina Caligiuri, Claudia Monaco, Rita L. Grillo, Antonio G. Rebuzzi,
Attilio Maseri. Cardiology, Catholic University, Rome, Italy
We have previously reported that elevated levels of an acute phase reactant.
C-Reactive Protein (CRP), are common in pts with unstable angina (UA) and
related to short term outcome. To assess whether the increase of CRP in
UA is a transient condition or persists after clinical stabilization, and whether
elevated levels of CRP after stabilization are still associated with prognosis,
we measured CRP in 34 patients (pts) with UA: blood samples were taken at
discharge from the hospital and 3 months (3 M) after the index event (during
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Successful PTCA for Post·lnfarction Ischemia is
Associated with Significantly Lower Long-term
Mortality
Improved Exercise Performance by Long-term
Enalapril Treatment in Patients with First
Anterior Myocardial Infarction: An One Year
Follow-up Study
Conclusions: In these generally asymptomatic patients, left ventricular
chamber dilatation, developing rapidly during the first weeks to months after
infarction, did not appear to advance after the first year; however, global left
ventricular hypertrophy developed more gradually with significant increases
in left ventricular muscle mass above baseline apparent by 4-5 years after
index anterior infarction. Furthermore, the VIM ratio, although elevated from
that determined at initial hospital discharge, suggested that wall tension was
decreasing by 4-5 years after infarction, probably as a direct consequence
to the late development of "reactive" left ventricular hypertrophy.
Prognosis after myocardial infarction (MI) is influenced by the occurrence
of post-myocardial infarction ischemia and by the presence of an open in-
farct related artery. Revascularization is performed in patients with post-
myocardial infarction ischemia to alleviate symptoms. Due to small num-
bers of patients in studies observing outcome after PTCA for post-infarction
ischemia, it has not been possible to determine outcome for patients with
open versus severely narrowed or closed vessels following PTCA. In this
study, we compared long-term outcome for reinfarction and death in patients
with open versus closed or severely narrowed coronary arteries following
PTCA for post-infarction ischemia.
505 consecutive patients undervvent PTCA for post-infarction ischemia at
Deaconess Hospital between 1981 and 1989. Follow-up (mean 34 months)
after hospital discharge for reinfarction, death, repeat PTCA and coronary
bypass grafting was then compared based on the status of the artery at the
end of angioplasty (open versus closed or severely narrowed). The 5-year
Kaplan-Meier actuarial mortality rate was 4.7% for patients with open vessels
and 11.4% for those with severely narrowed or closed vessels. Patients with
open vessels had a significantly lower mortality (p = 0.009) and mortality or
reinfarction (p = 0.007) as judged by the log-rank statistic. Multivariate Cox
proportional hazards analyses controlling for age, gender, type and location
of MI and year of PTCA revealed a hazard ratio for death for closed or severely
narrowed compared with open arteries of 4.7 (95% CI, 1.49-14.75) and for
the combined endpoint of MI or death of 3.2 (95% CI, 1.38-7.39).
Conclusion: Patients who undergo successful revascularization with PTCA
for post-infarction ischemia have significantly lower death rates than those
with severely narrowed or closed arteries following attempted PTCA.
Mani Vannan, Jean-Claude Tardif, Deryck Taylor, Michael Webb-Peploe,
Marvin Konstam. Tufts-New England Medical Center. Boston, Mass.
Angiotensin converting enzyme inhibitor (ACEI) therapy after MI reduces ven-
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a stable phase of the disease). Clinical follow-up of all pts was performed for
12 months.
Results: CRP values (normal <3 mg/l) are expressed as median and range.
At discharge, 13/34 pts (38%) had a CRP value >3 mgll (9 mgll, range 3.6-
29.2). and 21/34 pts (62%) had a CRP value <3 mgll (2.4 mgll, range 0.6-2.8).
All 13 pts with elevated CRP at discharge, but one, had elevated levels of
CRP also at 3 months, and 9 of them had a coronary event (2 pts myocardial
infarction, 7 pts recurrence of instability) within one year of follow-up (mean
159 ± 91 days). Conversely, only 1/21 pts with low CRP at discharge had a
myocardial infarction at 10 months (p < 0.001 vs pts with elevated levels at
dischargel; of note, at 3 months also this pt had increased levels of CRP
Conclusions: Our data suggest that in pts with UA, elevated CRP levels
at discharge and at 3 months (during a quiescent phase of the disease) are
associated with new coronary events (recurrence of instability and acute my-
ocardial infarction).
Myocardial Function, Physiology
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Differential Response of Left Ventricular Work
Efficiency and Inotropy to Dobutamine in the
Failing Canine Heart
Peter S. Rahko, Catherine R. Kidd, Alice M. Eggleston, Larry F Whitesell.
Cardiology Section, University of Wisconsin, Madison, WI
Left ventricular work efficiency (LVWE). a measure of the efficiency of energy
transfer from LV to systemic circulation, declines as heart failure ICHF) be-
comes more severe. We compared changes in the response of LVWE and
inotropy to dobutamine as progressively more severe CHF was induced by
tachypacing. Seventeen dogs (weights 19-24 kg) were instrumented with
micromanometer catheters, Ultrasonic crystals and a pacemaker and paced
at 215-240 bpm over 3 weeks. Ventricular volumes and pressures were dig-
itally acquired at baseline and weekly over 3 weeks. Pressure-volume area
(PVA), external work (EWI, end-systolic pressure-volume relation slope (E es )
and arterial elastance (Eal were derived from variably loaded beats after IVC
occlusion. The LVWE was calculated as EW/PVA. Measurements were made
with and without dobutamine (DOB) at 10 /Lg/kg/min.
Results:
Baseline CHF 1 CHF 2 CHF 3
EW{mmHg-ml) 1308 ± 663 1050 ± 542 861 ± 633- 738 ± 506-
% t on DOB +80 ± 34 +133 ± 71 +145± 89 +222 ± 188-
LVWE(%) 52 ± 8 42 ± 10- 36 ± 10- 33 ± ,,-
% t on DOB +65 ± 27 +77 ± 26 +108 ± 77- +115 ± 12-
Ees (mmHg/ml) 5.1 ± 2.9 3.8 ± 1.6 2.9 ± 1.6- 2.5 ± 10-
% t on DOB +269± 159 +135 ± 118- +125±31- +131 ± 58-
peak + dP/dt (mmHg/sl 1680 ± 482 1312 ± 354- 1008 ± 178- 1080 ± 325-
% ton DOB +162 ± 63 105 ± 49- lOB ± 52- +81 ± 42-
Ea/Ees ratio 20±08 3.7 ± 2.4- 4.1 ± 22- 4.1 ± 1.6-
%. on DOB -78± 11 -72 ± 9 -73 ± 9 -65 ± 4-
-p < 0.05 vs baseline
LV mass regression, since it exceedS 2 standard deviations of test-retest
reliability of M-mode echocardiography; such a large reduction in LV mass
should allow the detection of functional changes that accompany hypertro-
phy regression. Circumferential stress (ac, g/cm2) vs endocardial fractional
shortening (FSendo, %) relations were used to characterize LV function; ac
vs midwall fractional shortening (FSmw, %) was used to define myocardial
function. FSmw was derived from a two-shell model that accounts for non-
uniform wall thickening, is independent of relative wall thickness (RWT) and
is anatomically appropriate, since midwall fibers are oriented circumferen-
tially. Thd and Dd are LV diastolic wall thickness and diastolic dimension
(mm); SBP ~ systolic pressure;
Data are mean ± SE.
SBP Th d Dd RWT LVMass FSendo FSmw ac
baseline 153 ± 4 14 ± 1 56 ± 1 0.50 ± 0.03 438 ± 26 39 ± 2 20 ± 1 95 ± 10
1year 139 ± 4- 11 ± 1- 52 ± 2- 0.46 ± 0.03326 ± 24- 36 ± 2 20 ± 1 106 ± 12-
-P < 005 vs baseline
A significant decrease in SSP was accompanied by a substantial reduction
in LV mass and a significant, albeit small, increment in aC. The increase in ac
was associated with a small (p = NS) decrease in FSendo and no change in
FSmw. Thus major changes in mass associated with anti-hypertensive ther-
apy are not accompanied by a decrement in LV or myocardial function. In-
deed the unchanged FSmw in the presence of increased ac suggests im-
proved myocardial contractile function.
Combination of Myocardial Contrast
Echocardiography and Dobutamine
Echocardlography In the Assessment of
Myocardial Viability
Mario F. Meza, Marc A. Kates, R. Wayne Barbee, Susan Revall, Sameh Mobarek,
Joseph P. Murgo, Jorge Cheirif. Ochsner Medical Institutions, New Orleans, LA
Independent studies using myocardial contrast echocardiography (MCE)
and dobutamine-echocardiography have suggested that each of these tech-
niques can individually identify viable myocardium. To determine if the com-
bination of these techniques can be used to differentiate viable from non-
viable myocardium, we studied 35 open-chest dogs in which coronary oc-
clusions of various durations were performed (15 minutes to 360 minutes).
Myocardial contrast echocardiography (area under the time-intensity curve)
was performed with injections of sonicated albumin (Albunex®) in the aortic
root at baseline, during occlusion, and following reperfusion with and with-
out dobutamine administration. Regional function [% wall thickening (WT)],
was assessed during all interventions. Criteria for viability were: return of
perfusion (by MCE) and regional function (by WT) to preocclusion levels and
postmortem TIC staining (+ stain = viable myocardium). Results as shown
below (MI = myocardial infarction):
Sensitivity Specificity
Group MCE WT MCE + WT MCE WT MCE +WT
No Dobutamine:
NoMI 4B 36 61 100 100 100
MI 100 100 100 48 52 56
With Dobutamine:
NoMI 60 52 87 43 57 60
MI 100 86 100 60 52 62
Gerard P Aurigemma, John S. Gottdiener, William H. Gaasch. DaVid Williams,
Zahid Jamal, Domenic J. Reda, Barry J. Materson. University of Massachusetts
Medical School, Worcester, MA; Georgetown University Hospital. Washington D. C;
Department of Veterans Affairs
The inotropic responsiveness of the LV is significantly reduced in CHF as
demonstrated by the response of Ees and +dP/dt to DOB. However, EW on
DOB in CHF is not significantly different than at baseline (1924 ± 1205 vs
2269 ± 1051 mmHg-ml). This is caused by a greater increase in LVWE on
DOB in CHF Improved LVWE and Ea/Ees coupling is an important mechanism
for enhanced LV pump performance in CHF and helps counterbalance the
reduction of inotropic responsiveness of the LV as CHF progresses.
It has been hypothesized that left ventricular(LV)function may deteriorate fol-
lOWing reduction in LV mass in treated hypertensives. We therefore assessed
ventricular and myocardial function follOWing a substantial regression of LV
mass (~80 g) after 1 year of antihypertensive treatment in 17 patients. These
pts were part of a cohort of 239 undergoing echocardiography at baseline
and 1 year who took part in a multicenter VA cooperative study of monother-
apy in hypertension. We hypothesized that an 80 g reduction represents true
In conclusion, combination MCE-dobutamine echocardiography improves
the sensitivity and specificity of either technique alone in diagnosing the
presence of viable myocardium. This data could have important clinical im-
plications.
Determinants of Pulmonary Hypertension
Associated with Left Ventricular Dysfunction
MaUrice E. Sarano, James B. Seward, A. Jamil Tajik. Mayo Clinic, Rochester, MN
The elevation of systolic pulmonary artery pressure (S-PAP) is an important
prognostic variable in patients with left ventricular dysfunction (LVD). The
potential determinant of pulmonary hypertension have not been consistently
measured and remain ill defined. In 93 patients (age = 6B ± 13 years) with pri-
mary LVD (Ejection Fraction <50%, mean ± SO = 31 ± 10%), the S-PAP was
prospectively measured using Doppler tricuspid regurgitant velocity. The cor-
relations between S-PAP and LV diastolic volume (R = 0.19, P = NS). LVejec-
tion fraction (R = -0.23, p = 0.024). cardiac index (R = -0.22, P = 0.04). left
atrial volume (R = 0.31, P = 0.002) were weak. Stronger correlations were
observed with mitral regurgitant fraction (R = 0.46, p = 0.0001). effective
regurgitant orifice (ERO, R = 0.48, P = 0.0001), mitral deceleration time (DT)
R = -0.62, P = 0.0001) and E/A ratio (R = 0.43, P = 0.002). With multivariate
analysis, the only independent predictors of S-PAP were mitral deceleration
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Ventricular and Myocardial Function Following
Regression of Hypertensive Left Ventricular
Hypertrophy
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